Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for metachromatic leukodystrophy

T Ohashi1, K Watabe, Y Sato

  • 1Department of Pediatrics, University of Tokyo, Japan.

Acta Paediatrica Japonica : Overseas Edition
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distamycin A modulates the sequence specificity of DNA alkylation by duocarmycin A.

Proceedings of the National Academy of Sciences of the United States of America·1996
Same author

Soluble CD14 mediates lipopolysaccharide-induced intercellular adhesion molecule 1 expression in cultured human gingival fibroblasts.

Infection and immunity·1996
Same author

[Atherosclerosis and clinical examination: epidemiology of stroke and ischemic heart disease].

Rinsho byori. The Japanese journal of clinical pathology·1996
Same author

Risk of clot formation with ionic and nonionic contrast media in cerebral angiography. Tama Contrast Media Study Group.

Academic radiology·1996
Same author

Identification of two Xenopus laevis genes, xMCM2 and xCDC46, with sequence homology to MCM genes involved in DNA replication.

Gene·1996
Same author

Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae.

Antimicrobial agents and chemotherapy·1996

Gene therapy shows promise for metachromatic leukodystrophy (MLD). Recombinant adenovirus effectively delivered the arylsulfatase A (ASA) gene to brain cells and patient fibroblasts, correcting the metabolic deficiency without adverse effects.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Metachromatic leukodystrophy (MLD) is an inherited metabolic disorder caused by arylsulfatase A (ASA) deficiency.
  • This deficiency leads to cerebroside sulfate accumulation in brain oligodendrocytes, causing dysmyelination.

Purpose of the Study:

  • To evaluate the feasibility of gene therapy for MLD using recombinant adenovirus for ASA gene delivery.
  • To assess the impact of ASA gene overexpression on other sulfatases in MLD patient cells.

Main Methods:

  • Adenovirus vectors (Adex1SRLacZ and Adex1SRASA) were used to transduce oligodendrocytes and MLD patient fibroblasts.
  • Retrovirus vector (MFG-ASA) was employed to study the effects of ASA overexpression on other sulfatases.

Main Results:

Related Experiment Videos

  • Recombinant adenovirus efficiently transduced oligodendrocytes and expressed the ASA gene in MLD patient fibroblasts.
  • Overexpression of ASA resulted in a minor reduction in other sulfatase activities without inducing glycosaminoglycan accumulation.
  • The effects of ASA overexpression on sulfatases differ from those observed with N-acetygalactosamine-4-sulfatase.

Conclusions:

  • Recombinant adenovirus is a potential tool for transferring the ASA gene to the brain for MLD treatment.
  • Gene therapy for MLD is feasible, as ASA gene transfer corrects the deficiency without causing new phenotypes or severe impairment of other sulfatases.